Cargando…

Controlled Synthesis of Up-Conversion NaYF(4):Yb,Tm Nanoparticles for Drug Release under Near IR-Light Therapy

Up-Conversion materials have received great attention in drug delivery applications in recent years. A specifically emerging field includes the development of strategies focusing on photon processes that promote the development of novel platforms for the efficient transport and the controlled releas...

Descripción completa

Detalles Bibliográficos
Autores principales: Moyano Rodríguez, Edelweiss, Gomez-Mendoza, Miguel, Pérez-Ruiz, Raúl, Peñín, Beatriz, Sampedro, Diego, Caamaño, Antonio, de la Peña O’Shea, Víctor A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699023/
https://www.ncbi.nlm.nih.gov/pubmed/34944769
http://dx.doi.org/10.3390/biomedicines9121953
_version_ 1784620418153316352
author Moyano Rodríguez, Edelweiss
Gomez-Mendoza, Miguel
Pérez-Ruiz, Raúl
Peñín, Beatriz
Sampedro, Diego
Caamaño, Antonio
de la Peña O’Shea, Víctor A.
author_facet Moyano Rodríguez, Edelweiss
Gomez-Mendoza, Miguel
Pérez-Ruiz, Raúl
Peñín, Beatriz
Sampedro, Diego
Caamaño, Antonio
de la Peña O’Shea, Víctor A.
author_sort Moyano Rodríguez, Edelweiss
collection PubMed
description Up-Conversion materials have received great attention in drug delivery applications in recent years. A specifically emerging field includes the development of strategies focusing on photon processes that promote the development of novel platforms for the efficient transport and the controlled release of drug molecules in the harsh microenvironment. Here, modified reaction time, thermal treatment, and pH conditions were controlled in the synthesis of NaYF(4):Yb,Tm up-converted (UC) material to improve its photoluminescence properties. The best blue-emission performance was achieved for the UC3 sample prepared through 24 h-synthesis without thermal treatment at a pH of 5, which promotes the presence of the β-phase and smaller particle size. NaYF(4):Yb,Tm has resulted in a highly efficient blue emitter material for light-driven drug release under near-IR wavelength. Thus, NaYF(4):Yb,Tm up-converted material promotes the N-O bond cleavage of the oxime ester of Ciprofloxacin (prodrug) as a highly efficient photosensitized drug delivery process. HPLC chromatography and transient absorption spectroscopy measurements were performed to evaluate the drug release conversion rate. UC3 has resulted in a very stable and easily recovered material that can be used in several reaction cycles. This straightforward methodology can be extended to other drugs containing photoactive chromophores and is present as an alternative for drug release systems.
format Online
Article
Text
id pubmed-8699023
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86990232021-12-24 Controlled Synthesis of Up-Conversion NaYF(4):Yb,Tm Nanoparticles for Drug Release under Near IR-Light Therapy Moyano Rodríguez, Edelweiss Gomez-Mendoza, Miguel Pérez-Ruiz, Raúl Peñín, Beatriz Sampedro, Diego Caamaño, Antonio de la Peña O’Shea, Víctor A. Biomedicines Article Up-Conversion materials have received great attention in drug delivery applications in recent years. A specifically emerging field includes the development of strategies focusing on photon processes that promote the development of novel platforms for the efficient transport and the controlled release of drug molecules in the harsh microenvironment. Here, modified reaction time, thermal treatment, and pH conditions were controlled in the synthesis of NaYF(4):Yb,Tm up-converted (UC) material to improve its photoluminescence properties. The best blue-emission performance was achieved for the UC3 sample prepared through 24 h-synthesis without thermal treatment at a pH of 5, which promotes the presence of the β-phase and smaller particle size. NaYF(4):Yb,Tm has resulted in a highly efficient blue emitter material for light-driven drug release under near-IR wavelength. Thus, NaYF(4):Yb,Tm up-converted material promotes the N-O bond cleavage of the oxime ester of Ciprofloxacin (prodrug) as a highly efficient photosensitized drug delivery process. HPLC chromatography and transient absorption spectroscopy measurements were performed to evaluate the drug release conversion rate. UC3 has resulted in a very stable and easily recovered material that can be used in several reaction cycles. This straightforward methodology can be extended to other drugs containing photoactive chromophores and is present as an alternative for drug release systems. MDPI 2021-12-20 /pmc/articles/PMC8699023/ /pubmed/34944769 http://dx.doi.org/10.3390/biomedicines9121953 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Moyano Rodríguez, Edelweiss
Gomez-Mendoza, Miguel
Pérez-Ruiz, Raúl
Peñín, Beatriz
Sampedro, Diego
Caamaño, Antonio
de la Peña O’Shea, Víctor A.
Controlled Synthesis of Up-Conversion NaYF(4):Yb,Tm Nanoparticles for Drug Release under Near IR-Light Therapy
title Controlled Synthesis of Up-Conversion NaYF(4):Yb,Tm Nanoparticles for Drug Release under Near IR-Light Therapy
title_full Controlled Synthesis of Up-Conversion NaYF(4):Yb,Tm Nanoparticles for Drug Release under Near IR-Light Therapy
title_fullStr Controlled Synthesis of Up-Conversion NaYF(4):Yb,Tm Nanoparticles for Drug Release under Near IR-Light Therapy
title_full_unstemmed Controlled Synthesis of Up-Conversion NaYF(4):Yb,Tm Nanoparticles for Drug Release under Near IR-Light Therapy
title_short Controlled Synthesis of Up-Conversion NaYF(4):Yb,Tm Nanoparticles for Drug Release under Near IR-Light Therapy
title_sort controlled synthesis of up-conversion nayf(4):yb,tm nanoparticles for drug release under near ir-light therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699023/
https://www.ncbi.nlm.nih.gov/pubmed/34944769
http://dx.doi.org/10.3390/biomedicines9121953
work_keys_str_mv AT moyanorodriguezedelweiss controlledsynthesisofupconversionnayf4ybtmnanoparticlesfordrugreleaseundernearirlighttherapy
AT gomezmendozamiguel controlledsynthesisofupconversionnayf4ybtmnanoparticlesfordrugreleaseundernearirlighttherapy
AT perezruizraul controlledsynthesisofupconversionnayf4ybtmnanoparticlesfordrugreleaseundernearirlighttherapy
AT peninbeatriz controlledsynthesisofupconversionnayf4ybtmnanoparticlesfordrugreleaseundernearirlighttherapy
AT sampedrodiego controlledsynthesisofupconversionnayf4ybtmnanoparticlesfordrugreleaseundernearirlighttherapy
AT caamanoantonio controlledsynthesisofupconversionnayf4ybtmnanoparticlesfordrugreleaseundernearirlighttherapy
AT delapenaosheavictora controlledsynthesisofupconversionnayf4ybtmnanoparticlesfordrugreleaseundernearirlighttherapy